Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 27.00
-0.30 (-1.10%)
Oct 20, 2026, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 3.49 billion as of October 20, 2026. It is the 24,749th most valuable company in the world and the 1,306th biggest in Taiwan. Its market cap has decreased by 49.87% in one year.
Market Cap
3.49B
Enterprise Value
2.90B
Revenue
53.38M
Global Rank
Country Rank
#1,306 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 3.49B, a decrease of -28.20%. That is a compound annual growth rate of -6.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 3.49B | -47.94% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UnicoCell Biomed | 4.43B |
| Sunhawk Vision Biotech | 4.36B |
| Sinew Pharma | 4.26B |
| Formosa Pharmaceuticals | 3.83B |
| SYN-TECH Chem. & Pharm. | 3.38B |
| Great Novel Therapeutics Biotech & Medicals | 3.33B |
| Shine-On BioMedical | 3.30B |
| BioGend Therapeutics | 3.28B |